Svetlozar Natov MD in Weymouth, Massachusetts

Medical School: Sorry, his university is not listed
Graduation Year: 1979
The Primary Medical Specialty for Svetlozar Natov MD is listed as: Internal Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 45
PAC (PECOS ID)#: 9739164401
NPI #: 1255485249
NPI Created On: 01/23/2007
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207R00000X
License Number:
152333
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Harvard Pilgrim Health Care Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: French, Russian, Bulgarian.

---

Services and Procedures include:

1. Hemodialysis procedure with one physician evaluation
2. Established patient office or other outpatient visit, typically 15 minutes
3. Established patient office or other outpatient, visit typically 25 minutes
4. Initial hospital inpatient care, typically 70 minutes per day
5. Subsequent hospital inpatient care, typically 25 minutes per day
6. Subsequent hospital inpatient care, typically 35 minutes per day
7. Hospital discharge day management, more than 30 minutes
8. Initial nursing facility visit, typically 45 minutes per day
9. Initial nursing facility visit, typically 45 minutes per day
10. Subsequent nursing facility visit, typically 15 minutes per day
11. Subsequent nursing facility visit, typically 15 minutes per day
12. Subsequent nursing facility visit, typically 25 minutes per day
13. Nursing facility discharge management, more than 30 minutes
14. Nursing facility discharge management, more than 30 minutes
15. Physician telephone patient service, 11-20 minutes of medical discussion
16. Physician telephone patient service, 21-30 minutes of medical discussion
17. Physician telephone patient service, 21-30 minutes of medical discussion

They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.